Dexcom (DXCM) FY2018 results: revenue $1.0 billion, up 43.6% on the year
Dexcom Inc. (DXCM) reported revenue of $1.0 billion for fiscal 2018, the year ended 31 December 2018, up 43.6% on the year before. Net income was -$127 million, and diluted earnings per share $-1.44. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2019.
Revenue
$1.0 billion
+43.6% on the year
FY2011FY2018
Operating margin
-18.1%
-5.9% a year earlier
FY2011FY2018
Net income
-$127 million
FY2011FY2018
Diluted EPS
-$1.44
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
1,032
718
573
+43.6%
Cost of revenue
368
226
195
+62.4%
Gross profit
664
492
378
+34.9%
Gross margin
64.4%
68.5%
66.0%
Research and development
200
185
156
+7.7%
Selling, general and administrative
433
349
286
+23.9%
Operating income
-186
-42.5
-63.9
Operating margin
-18.1%
-5.9%
-11.1%
Interest expense
22.7
12.8
0.7
+77.3%
Pre-tax income
-126
-48.6
-64.9
Income tax
0.6
1.6
0.7
-62.5%
Net income
-127
-50.2
-65.6
Net margin
-12.3%
-7.0%
-11.4%
Diluted EPS
-$1.44
-$0.58
-$0.78
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
123
92.0
56.2
+33.9%
Capital expenditure
67.1
66.0
55.7
+1.7%
Free cash flow
56.1
26.0
0.5
+115.8%
Free cash flow margin
5.4%
3.6%
0.1%
Cash from investing
-140
-144
-55.9
Cash from financing
710
399
8.1
+78.0%
Depreciation and amortisation
29.1
16.1
15.0
+80.7%
Share-based compensation
102
106
111
-4.0%
Buybacks
100
0.0
0.0
Diluted shares, weighted
88m
86m
n/a
+2.2%
Shares outstanding at period end
90m
87m
85m
+3.4%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
663
419
284
+58.2%
Debt
1,010
328
0.0
+208.4%
Operating lease liabilities
0.0
n/a
n/a
Other liabilities
242
157
119
+54.3%
Total liabilities and equity
1,916
904
403
+111.9%
Fixed assets
183
146
109
+25.8%
Goodwill
18.7
12.1
11.3
+54.5%
Intangible assets
n/a
n/a
0.2
Investments
107
122
35.1
-11.9%
Cash and equivalents
1,137
442
94.5
+157.5%
Receivables
227
134
102
+68.8%
Inventory
70.7
45.2
45.4
+56.4%
Other assets
173
3.9
5.2
+4,328.2%
Total assets
1,916
904
403
+111.9%
10-K for the year ended 31 December 2018, filed 21 February 2019: the filing.